PharmEasy’s ₹3,500 crore rights issue oversubscribed, co-founder Siddharth Shah to have 3-year lock-in for remaining stake

Fresh details are emerging from PharmEasy’s much sought after rights issue. The…

PharmEasy to raise ₹2500 crore from Manipal group, others, that includes a significant valuation drop

PharmEasy, the health tech startup whose own financial health was pretty bleak…

PharmEasy shelves IPO plans, opts for a rights issue instead

An ambitious attempt by several of India’s high profile tech unicorns to…

Healthtech unicorn PharmEasy to acquire 66% stake in publicly listed diagnostics major Thyrocare

The Indian healthcare sector has gone online in recent times, a trend…

Pharmeasy acquires Medlife to create India’s largest medicine delivery platform

With COVID 19 once again rearing its ugly head in India, the…

PharmEasy parent API Holdings latest to enter India’s unicorn club with valuation of $1.5 billion

We are only halfway through the week and already India’s blooming startup…

Medlife to merge with PharmEasy, combined entity reportedly valued at $1.2 billion

Two of India’s most prominent healthtech startups are announcing merger today, in…